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Abstract: For bone regeneration and repair, combinations of different materials are often
needed. Biodegradable polymers are often combined with osteoconductive materials, such as
bioactive glass (BaG), which can also improve the mechanical properties of the composite. The
aim of this work was to develop and characterize BaG fiber reinforced starch–poly-e-
caprolactone (SPCL) composite. Sheets of SPCL (30/70 wt %) were produced using single-
screw extrusion. They were then cut and compression-molded in layers with BaG fibers to
form composite structures with different combinations. Mechanical and degradation proper-
ties of the composites were studied. The actual amount of BaG in the composites was
determined using combustion tests. Initial mechanical properties of the reinforced composites
were at least 50% better than the properties of the nonreinforced specimens. However, the
mechanical properties of the composites after 2 weeks of hydrolysis were comparable to those
of the nonreinforced samples. During the 6 weeks hydrolysis the mass of the composites had
decreased only by about 5%. The amount of glass in the composites remained as initial for the
6-week period of hydrolysis. In conclusion, it is possible to enhance initial mechanical
properties of SPCL by reinforcing it with BaG fibers. However, mechanical properties of the
composites are typical for bone fillers and strength properties need to be further improved for
allowing more demanding bone applications. ' 2008 Wiley Periodicals, Inc. J Biomed Mater Res Part
B: Appl Biomater 87B: 197–203, 2008
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INTRODUCTION
Starch is used in blends with other biodegradable polymers
as it is known to be biodegradable, it is economically feasi-
ble, it is easy to convert into a thermoplastic polymer, and
it has good availability.1–3 So far, there are several starch-
based blends which have been studied. Starch has been
blended at least with ethylene vinyl alcohol,1–2,4–11 cellu-
lose acetate,2,4–7,12 polylactide,5,13 and poly-e-caprolactone
(SPCL).1,5–7,14,15 Starch-based polymers are nowadays
manufactured for various applications, for example to
agriculture applications and packaging segments.16 In addi-
tion they have shown to have good potential to be used
in different biomedical applications, especially in bone
applications such as tissue engineering scaffolds, bone
cements, drug-delivery applications, or bone fixation
devices.1,3,4,6–8,14,15
SPCL is a potential new biocompatible and biodegrad-
able blend which is studied to be used in bone applica-
tions. It has shown relatively good biocompatibility.3,6,7,14
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Studies have shown that degradation of SPCL is enzy-
matic.1 a-Amylase is mainly responsible for the degrada-
tion of starch, but also glucoamylase and some other
enzymes can affect to the rate of degradation. PCL also
degrades by enzymatic oxidation and/or hydrolysis after
implantation. Enzymes that affect to the degradation of
PCL are lipase, cholesterol esterase, and carboxyl esterase.
These enzymes are present in the human body, and they
catalyze the hydrolysis of the ester bonds present in poly-
esters.
Bioactive glass (BaG) is a group of inorganic materials
which is well known for its bioactive properties. When
implanted into a bone, BaG remodels to form hydroxy car-
bonate apatite, which is the chemical and structural equiva-
lent of bone mineral. This leads to the formation of a bond
with the bone. BaG has been compounded with synthetic
and natural polymers or their combinations not only
because of its bioactivity, but also for reinforcing pur-
poses.17,18–20 In this study we used BaG 1-98. The mechan-
ical properties of BaG 1-98 has been studied and compared
to other bioactive glasses.21 The diameter of the fibers stud-
ied was 20–35 lm. It was found that the tensile strength of
the glass fibers 1-98 was about 2200 MPa, and it was the
highest obtained in this study for bioactive glasses. How-
ever, the mechanical strength is lost fast, so that after
immersion in Na-PBS for 2 h the mechanical strength of
the fibers is only about 310 MPa. Bioactive glasses 1-98
and 13-93 have much in common in their compositions;
however, the strength properties of BaG 1-98 are remark-
ably higher than for BaG 13-93 fiber (about 1350 MPa).
Pirhonen et al. studied the tensile strength properties of
BaG 9-93, and they found that the tensile strength glass
fibers (diameter 20–40 lm) was 1625 MPa.22 Average ten-
sile strength of BaG 45S5 fibers (diameter 79 lm) has been
reported to be about 340 MPa.23
The problem with many current biodegradable screws
and plates is the lack of osteoconductive properties. Our
attempt in the current study was to develop a material that
can be osteoconductive and can be used to develop devices
for reparative medicine (e.g., plates, screws, filling materi-
als) and potentially for regenerative medicine (scaffolds).
Practically, the aim of this study was to develop and char-
acterize BaG fiber-reinforced SPCL composite. BaG 1-98
fibers were chosen to be used as reinforcing material
because they have high initial mechanical strength and they
also add bioactivity to the implant.24 The properties of the
composite were studied during the 6-week hydrolysis.
MATERIALS AND METHODS
Materials
SPCL (30/70 wt %) polymer (Novamont, Novara, Italy)
was kindly donated by University of Minho, 3B’s Research
Group. It was a blend material in the form of small gran-
ules containing 70 wt % PCL and 30 wt % starch. Bioac-
tive glass 1-98 (BaG) fibers (Tampere University of
Technology, Institute of Biomaterials) were used for rein-
forcement of the polymer (diameter, 31–43 lm). The com-
position and manufacturing of the BaG fibers is presented
in previous studies.24
Processing
The polymer was extruded into a thick sheet using a sin-
gle-screw extruder Gimac Microextruder TR 12/24 B.V.O
(Gimac di Maccagnan, Castronno, Italy) and a rectangular
nozzle die (40 mm 3 0.5 mm). The polymer was fed into
the extruder using a feeding unit with nitrogen atmosphere.
Processing temperatures in heating elements were 110–
1508C. The thickness of the processed billet was 0.6 mm
and the width was 30 mm. The billet was further cut to
10 mm 3 50 mm 3 0.6 mm pieces for the compression
molding.
BaG fibers (diameter 31–43 lm, length 250 mm) were
bound together using SPCL-acetic acid solution before
compression molding for ease of handling. First, the poly-
mer was dissolved in to acetic acid to obtain a solution of
6 wt % of SPCL. Then about 3 g of the BaG fibers were
laid unidirectionally into a Teflon mold (10 cm 3 19 cm)
and moistened with about 25 mL of polymer–solvent solu-
tion that was spread all over the fibers. The mold was left
in the fume chamber until the next day. The larger mem-
brane was removed from the mold and cut to pieces
(10 mm 3 50 mm). BaG membranes and SPCL sheets
were compression molded to composite structures (NIKE
Hydraulics ZB110, NIKE Hydraulics Ab, Eskilstuna,
Sweden). Parameters used in processing the samples were
as follows: temperature 908C, pressure 10 MPa, and a heat-
ing time of 1.5 min after reaching the maximum tempera-
ture. Data about the manufactured specimens is presented
in Table I.
Characterization In Vitro
In vitro tests were performed using a phosphate buffered
solution, containing NaOH (0.04 mol/L) and KH2PO4
(0.05 mol/L). The pH of the solution was 7.4 6 0.05 and
the incubation temperature was 378C. In vitro studies were
carried out in static conditions. The amount of buffer solu-
tion was about 30 times the weight of the sample, accord-
ing to the standard ISO 15814:1999(E), and it was changed
weekly.25 For the samples tested for bending and shear
strength, the amount of the buffer solution was 60 mL, and
for the samples tested for tensile strength, the amount of
the buffer solution was 30 mL. When changed, pH of the
in vitro solution was measured. Measurements were done
using Mettler Toledo MP125 pH meter (Mettler Toledo).
There were six parallel samples at each time point, and the
total incubation period was 6 weeks. Material characteris-
tics were measured at follow-up points of 0, 2, 4, and
6 weeks.
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Mass Changes. Changes in mass of the 6xSPCL and
6xSPCL15xBaG samples were followed during the hydro-
lysis. The measurements were made using Mettler Toledo
AT261 DeltaRange1 precision scales (Mettler Toledo).
The initial mass of the samples was measured prior to incu-
bation. Immediately upon removal from the incubation so-
lution, the wet mass of the specimens was measured. The
specimens were then dried in a fume chamber for at least
72 h and then in the vacuum chamber at room temperature
for 24 h. Subsequently, the dry mass of the samples was
measured. Three parallel samples from both series
(6xSPCL and 6xSPCL15xBaG) were measured at each
time point.
Mechanical Properties. The mechanical properties of
the specimens were followed during the hydrolysis by
means of shear, bending, and tensile tests. Tests were per-
formed using Instron 4411 material testing machine (Ins-
tron, High Wycombe, England). Sample types, sizes, glass
contents in the samples, and the amounts of tested pieces
are shown in Table I.
Shear strength was determined by modifying the stand-
ard BS 2782,26 the size of the tested samples was different
than in the standard. The shear strength of each piece was
calculated as follows:
S ¼ F
BT
ð1Þ
where S is the shear strength (in MPa), F is the force (in
N) at fracture, B is the mean width (in mm) of the test pi-
ece, and T is the mean thickness (in mm) of the test piece.
Shear tests were performed using 5 kN cell. The crosshead
speed was 10 mm/min. Shear strength was tested perpen-
dicular to the glass fibers.
Bending strength and strain at maximum load were
determined by modifying the standard SFS-EN ISO 178.27
The size of the tested samples was not as it is recom-
mended in the standard, and that is why the test set up was
modified also by means of the radius of the testing parts
loading nose and the radius of the edges of the supports
and the distance between the edges of the supports. In addi-
TABLE I. Names, Structures, Sizes, BaG Contents, Amount of Tested Samples, and Test Procedures Performed for Different Kinds
of Samples Made from Extruded SPCL Sheets and BaG Membranes by Using Compression Molding As a Method
Name Structure
Size of the
sample (mm)
(w 3 l 3 t)
BaG
content
(wt %)
Amount of
tested
samples
Mechanical
test procedure
6xSPCL 10 3 50 3 3 0 3 Bending
6xSPCL15xBaG 10 3 50 3 3.7 13 6 2 3 Bending
6xSPCL 8 3 50 3 3 0 6 Shear
6xSPCL15xBaG 8 3 50 3 3.3 13 6 1 6 Shear
3xSPCL *Thickness, 1.4 0 6 Tensile
3xSPCL12xBaG *Thickness, 1.6 10 6 1 6 Tensile
3xSPCL14xBaG *Thickness, 1.8 17 6 2 6 Tensile
3xSPCL16xBaG *Thickness, 1.9 21 6 3 6 Tensile
Black lines indicate SPCL sheet and gray lines BaG membrane.
* The test specimen was as follows: a 5 45 mm, b 5 25 mm, c 5 20 mm, d 5 6 mm, e 5 10 mm.
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tion, there were only three parallel samples. The radius of the
testing parts loading nose was 5 mm, and the radius of the
edges of the supports was 1.5 mm. The distance between the
edges of the supports was 32 mm. Bending tests were per-
formed using 500 N cell. Speed of testing was 10 mm/min.
Bending strength was tested perpendicular to the glass fibers.
The test for determining the ultimate tensile strength
and the strain at maximum load was done according the
standard SFS-EN ISO 527-1.28 Tensile strength was meas-
ured by drawing the sample at a constant speed parallel to
the glass fibers and measuring the strength resisting the
strain until the sample broke or elongated for 30 mm. The
cell used in tensile tests was 5 kN, and the crosshead speed
was 20 mm/min. The gauge length was 20 mm and the
grip distance 25 mm.
BaG Amount in the Composites. The actual amount of
glass fiber in the composites was measured by utilizing the
combustion test modified from standard ISO 1172.29 The
actual amount of glass in the composites can be calculated
using following Eq. (2)
P ¼ m3 $ m1
m2 $ m1 3 100 ð2Þ
where m1 is the weight of the crucible, m2 is the weight of
the crucible and specimen, and m3 is the weight of the cru-
cible and inorganic fraction. Standard ISO 1172 was modi-
fied because the initial mass of the samples was not
enough (standard requires at least 2 g) and because there
were only three parallel samples when studying bending
tested samples (the standard requires at least four samples).
The glass amount was determined for all mechanically
tested samples (contents given as averages).
RESULTS
Processing
It was possible to utilize extrusion as processing method
for SPCL to produce sheet. Solvent casting using acetic
acid as a solvent for SPCL was feasible when manufactur-
ing the BaG membranes. By using compression molding, it
was easy to manufacture the final composites, although the
process was quite slow.
Changes in pH
The change in the pH of the buffer solution during the deg-
radation test indicates the effect of BaG when compared to
pure SPCL. The results are presented in Figure 1. In the
samples containing bioactive glass, the pH remained at
7.39 for the first 3 weeks, while the pH of the samples
without BaG was about 7.35. There was a small drop for
both samples at the 4 weeks in vitro but at 5 weeks the pH
increased about 0.1 U. Then at the 6 weeks, the pH of both
samples again decreased about 0.05 U. It seems that the
pH of the samples containing BaG was about 0.05 U higher
after the 6 weeks in hydrolysis than the pH of the samples
containing only SPCL. However, the difference was not re-
markable.
Mass Change
There were no major differences between the plain samples
or composites. After 2 weeks hydrolysis, the wet mass was
about 10% higher than the dry mass of the samples and
this remained same for the 6 weeks of hydrolysis. The dry
mass of the samples decreased about 5% from the initial
after 2 weeks in hydrolysis and remained the same for the
rest of the hydrolysis.
Changes in Mechanical Properties
Results from shear strength tests are presented in Figure 2.
The initial shear strength of the BaG fiber reinforced com-
posites (25 MPa) was about 56% higher than the shear
strength of the samples without the BaG fibers (16 MPa).
However, after 2 weeks of hydrolysis, the shear strength of
both types of sample was about the same (10 MPa) and
this continued for the 6 weeks hydrolysis.
Changes in bending strengths are presented in Figure 3.
The initial bending strength of the BaG fiber reinforced
composites (50 MPa) was about 66% higher than that of
Figure 1. Changes in pH during 6 weeks hydrolysis in samples with
and without BaG.
Figure 2. Changes in shear strength in vitro for 6xSPCL15xBaG
and 6xSPCL series.
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the polymer blend samples (30 MPa). After 2 weeks of hy-
drolysis, the bending strength of both types of samples had
decreased being 15 MPa for 6xSPCL and 24 MPa for
6xSPCL15xBaG. Strain at maximum load increased
slightly during hydrolysis for both series; more with the
composite series. For the series 6xSPCL, the strain was
first at 0.1 mm/mm and it increased to 0.14 mm/mm. The
initial strain for the series 6xSPCL15xBaG was 0.05 mm/
mm and increased to 0.15 mm/mm.
Results from tensile strength tests are presented in Fig-
ure 4. Initial tensile strength was highest for the series that
contained the smallest amount of BaG fibers (26 MPa) and
lowest for the series without reinforcement (17 MPa). After
2 weeks of hydrolysis of the series reinforced with BaG
fibers, tensile strengths were almost equal (10–14 MPa)
and this behavior remained the same for the rest of the
hydrolysis.
BaG Content
Initial amounts of BaG in different composites are pre-
sented in Table I. Within the hydrolysis, there were some
changes in the amount of BaG in the samples, which, how-
ever, remained within variation.
DISCUSSION
Polymers blended with starch have been studied for differ-
ent bone applications 2,4,8,12–15,30. Blending with starch
may have an effect on degradation time and on mechanical
properties of the resulting blends. Starch is a polysaccha-
ride and due to its heteropolymeric nature (macromolecular
backbone containing oxygen atoms), it is expected that bio-
degradation mediated by enzymes may occur as in the case
of chitosan.31 However, more studies are needed to investi-
gate the degradation of starch-based polymers in vivo.
pH changes during the hydrolysis were quite small for
both kinds of samples, and pH varied between 7.35 and
7.45 during the 6 weeks hydrolysis. But, still through the
6 weeks period of hydrolysis the samples with BaG had
higher pH. This behavior has also been seen in other stud-
ies where BaG and biodegradable polymer has been com-
pounded,19 and it is possibly due to the surface reactions of
BaG, which occur from the contact with buffer solution.32
The pH of the 6xSPCL series was slightly lower than the
initial pH of the buffer solution for the first 4 weeks. This
is due to the degradation of PCL, which usually begins
with random hydrolytic break of the ester linkages autoca-
talyzed by the acidic carboxyl end groups, decreasing the
pH of the solution.33 However, the changes during the hy-
drolysis were small and the pH was near the physiological
pH (7.4). BaG seemed to neutralize the acidic effect of
PCL degradation products.
There were no major mass changes of the samples dur-
ing the hydrolysis. Weight loss was similar for both kinds
(6xSPCL, 6xSPCL15xBaG) of samples. Usually, the deg-
radation of PCL starts with the continuous decrease in the
molar mass, but there is no weight loss during the first
stage of the degradation.33 Because of quite short hydroly-
sis study, it may be that the degradation had not yet pro-
ceeded to the second stage, where the decrease of mass is
faster. Molar mass was not followed up during this study.
Water absorbing ability of both kinds of samples was quite
similar.
It was possible to obtain at least 50% higher initial me-
chanical properties for the compression-molded SPCL sam-
ples by using BaG fiber reinforcement. However, after
2 weeks in hydrolysis, the strengths were quite close to
nonreinforced controls and they were lower than the
strength of bone (e.g., the shear strength of cancellous bone
is 1–21.4 MPa34). It can be assumed that the matrix carries
most of the load and BaG did not reinforce after 2 weeks
in hydrolysis. When BaG amount was determined using
burning test, the results showed that it did not change dur-
ing the 6-week hydrolysis. It should be noted that some
amount of BaG might have been remodeled to hydroxyapa-
tite (HA) precipitation, which was not determined during
this study. However, it can be assumed that the mechanical
properties of the fibers have changed, so that they do not
have enough mechanical strength to carry almost any load.
Probably, the amount of BaG (or HA precipitation)
remained the same during the hydrolysis, because it was
between the polymer layers where it was difficult to
escape. Mechanical properties of the composites were not
Figure 4. Changes in tensile strength in vitro for 3xSPCL,
3xSPCL12xBaG, 3xSPCL14xBaG, and for 3xSPCL16xBaG series.
Figure 3. Changes in bending strength in vitro for 6xSPCL15xBaG
and 6xSPCL series.
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found to be adequate for bone fracture fixation applications.
Although the initial strength of the composites was higher
than the strength of bone, for bone fixation applications,
longer lasting and higher mechanical properties are needed.
Higher strengths have also been achieved for rods made
from polyglycolide or poly-L-lactide, which are commonly
used materials for bone fixation implants.34,35
CONCLUSIONS
BaG fiber-reinforced composites were manufactured by
using compression molding from extruded SPCL billet and
BaG fiber sheet. Nonreinforced samples were used as refer-
ence. It was possible to obtain at least 50% higher initial
mechanical properties by reinforcing the samples with BaG
fibers. However, mechanical properties decreased to same
level as non-reinforced controls after 2 weeks in hydrolysis.
During the 6-week hydrolysis, the mass of both kinds of
samples, reinforced with BaG and non-reinforced,
decreased only about 5%. The amount of BaG in the com-
posites remained the same for the 6-week period in hydro-
lysis, thus mechanical properties of the BaG fibers had
changed dramatically.
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